Nightingale Health Accelerates the Availability of Its At-Home Blood Testing Solution by Launching an Early-Access Pilot for 10,000 Consumers in Finland
Finnish health tech company Nightingale Health Oy (“Nightingale”) today announced that the availability of its pioneering blood test is extending from physical locations also directly to people’s homes. Due to recent innovations discovered in Nightingale’s laboratory R&D, the solution is launching as an early-access pilot in Finland for 10,000 consumers starting in the second quarter of 2021.
The solution is based on self-collected finger-prick blood sample. Consumer subscribes to the service online and a Nightingale self-collection kit will be shipped directly to the home address. The